felodipine has been researched along with Diabetic Glomerulosclerosis in 6 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "With ramipril treatment urinary albumin creatinine ratio (14." | 6.68 | Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. ( Hoffmann, W; Hopmeier, P; Schernthaner, G; Schnack, C, 1996) |
| "With ramipril treatment urinary albumin creatinine ratio (14." | 2.68 | Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. ( Hoffmann, W; Hopmeier, P; Schernthaner, G; Schnack, C, 1996) |
| "Enalapril treatment (5 mg/kg/day, n = 11) or felodipine (30 mg/kg/day, n = 11) reduced systolic blood pressure to a comparable degree." | 1.27 | Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. ( Cubela, R; Debrevi, L; Jackson, B; Johnston, CI; Whitty, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, YH | 1 |
| Sarriff, A | 1 |
| Adnan, AS | 1 |
| Khan, AH | 1 |
| Malhi, TH | 1 |
| Jummaat, F | 1 |
| Spångberg-Viklund, B | 1 |
| Berglund, J | 1 |
| Nikonoff, T | 1 |
| Nyberg, P | 1 |
| Skau, T | 1 |
| Larsson, R | 1 |
| Schnack, C | 1 |
| Hoffmann, W | 1 |
| Hopmeier, P | 1 |
| Schernthaner, G | 1 |
| Sawicki, PT | 1 |
| Jungmann, E | 1 |
| Schumm-Draeger, PM | 1 |
| Scheuermann, EH | 1 |
| Usadel, KH | 1 |
| Jackson, B | 1 |
| Cubela, R | 1 |
| Debrevi, L | 1 |
| Whitty, M | 1 |
| Johnston, CI | 1 |
3 trials available for felodipine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function?
Topics: Aged; Aged, 80 and over; Angiography; Calcium Channel Blockers; Contrast Media; Creatinine; Diabetes | 1996 |
Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.
Topics: Adrenergic beta-Antagonists; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atenolol; | 1996 |
Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimens. Diabetes Treatment and Teaching Programmes Working Group.
Topics: Adult; Antihypertensive Agents; Diabetic Nephropathies; Felodipine; Female; Follow-Up Studies; Glome | 1997 |
3 other studies available for felodipine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Complications associated with End Stage Renal Disease.
Topics: Ceftazidime; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Nephropathies; Diabetic Neuropathies | 2015 |
[Long-term antihypertensive therapy of diabetic patients with felodipine. Effects of treatment on blood pressure and kidney function parameters].
Topics: Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Felodi | 1992 |
Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Diabetes Mellitus, Expe | 1987 |